bluebird bio, Inc. BLUE
At closeJun 2, 2025, 4:00 PM EDT
52-week range unavailable
- YTD
- -40.41%
- 1 year
- -72.25%
Discussion (235)
Sign in to join the discussion
You have 6 months to put up or shit up because the well will be dry next round
They should halt all clinical research and focus 100% on launch and sell asap while these a viable sound financial situation. This is a gamble that the unrealistic market will deliver. I have seen great product die because of such poor research based management. You need a pro that can sell the fucking products.
Have sickle cell and let them say it’s not juice isn’t worth the squeeze! Have you ever been in bone crushing pain and have a doctor tell you he can’t give you pain meds because some people get addicted??
Keytruda has a black box BFD!
You have to have a pair of big ones and ride this out. The valuation is so exaggerated it’s like listening to a Trump rally.
If they will have 400 million in cash and 3 approved drugs wall steer is now saying it’s worth 200 million? I think MAGA’s thought process has infected Wall Street
Settle in because the legal crap makes watching this like watching grass grow
It’s like a cop going to a domestic fight
Until the legal date settled you can forget a buyout. The buyers won’t go near it
Longs should bums rush the investor relations with phone calls and shake them up
